Poly Medicure Limited (POLYMED) Stock Statistics & Valuation Metrics

Poly Medicure Limited has a market cap or net worth of ₹170.29B. The enterprise value is ₹158.51B.

Poly Medicure Limited has 101,359,490 shares outstanding. The number of shares has decreased by -2.65% in one year.

Poly Medicure Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.74%.

The current PE Ratio of Poly Medicure Limited is 54.5. Poly Medicure Limited’s PEG ratio is -5.89.

In the last 12 months, Poly Medicure Limited had revenue of 18.75B and earned 3.22B in profits. Earnings per share was 31.79.

In the last 12 months, operating cash flow was 914.43M and capital expenditures -1.57B, giving a free cash flow of -658.89M billion.

Poly Medicure Limited pays an annual dividend of ₹3.5, resulting in a dividend yield of 0.19%

Poly Medicure Limited upcoming earnings date is Jul 29, 2026, TBA (Confirmed).

Poly Medicure Limited as a current ratio of 3.37, with Debt / Equity ratio of 11.38%

In the past 12 months, Poly Medicure Limited has paid 1.07B in taxes.

Poly Medicure Limited EV to EBITDA ratio is 23.64, with an EV/FCF ratio of -220.52.

Poly Medicure Limited has ₹11.06B in cash and marketable securities with ₹2.40B in debt, giving a net cash position of ₹8.67B billion.

Gross margin is 46.49%, with operating margin of 17.43%, and net profit margin of 17.18%.

The average price target for Poly Medicure Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―